Synthesis and Biological Evaluation of 5'-O-Fatty Acyl Ester Derivatives of 3'-Fluoro-2',3'-dideoxythymidine as Potential Anti-HIV Microbicides. 2022

Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
Department of Pharmaceutical Sciences, School of Pharmacy, South University, 709 Mall Boulevard, Savannah, GA 31406, USA.

A number of 5′-O-fatty acyl derivatives of 3′-fluoro-2′,3′-dideoxythymidine (FLT, 1) were synthesized. These conjugates were evaluated for their potential as topical microbicides with anti-HIV activity against cell-free (X4 and R5), cell-associated, and multidrug-resistant viruses. Compared to FLT and 3′-azido-2′,3′-dideoxythymidine (AZT), 5′-O-(12-azidododecanoyl) (5), 5′-O-myristoyl (6), and 5′-O-(12-thioethyldodecanoyl) (8) derivatives of FLT were found to be more active against both cell-free viruses (lymphocytotropic and monocytotropic strains) with EC50 values of 0.4 μM, 1.1 μM, and <0.2 μM, respectively, as well as cell-associated virus with EC50 values of 12.6, 6.4, and 2.3 μM, respectively. Conjugates 5, 6, and 8 exhibited >4 and >30 times better antiviral index than FLT and AZT, respectively. Conjugates 5 and 8 were significantly more potent than FLT against many multidrug-resistant strains. A comparison of the anti-HIV activity with the corresponding non-hydrolyzable ether conjugates suggested that ester hydrolysis to FLT and fatty acids is critical to enable anti-HIV activity. Cellular uptake studies were conducted using fluorescent derivatives of FLT attached with 5(6)-carboxyfluorescein through either β-alanine (23) or 12-aminododecanoic acid (24) spacers. The lipophilic fluorescent analog with a long chain (24) showed more than 12 times higher cellular uptake profile than the fluorescent analog with a short chain (23). These studies further confirmed that the attachment of fatty acids improved the cellular uptake of nucleoside conjugates. In addition, 5, 6, and 8 were the least cytotoxic and did not alter vaginal cell and sperm viability compared to the positive control, a commercial topical spermicide (N-9), which significantly decreased sperm and vaginal cell viability inducing the generation of proinflammatory cytokines.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
April 2011, Bioorganic & medicinal chemistry letters,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
June 1998, Nucleosides & nucleotides,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
June 2016, European journal of medicinal chemistry,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
March 2014, Tetrahedron letters,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
March 2012, Medicinal chemistry (Shariqah (United Arab Emirates)),
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
January 1998, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
January 2003, Nucleosides, nucleotides & nucleic acids,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
January 1999, Nucleosides & nucleotides,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
October 2010, European journal of medicinal chemistry,
Hitesh K Agarwal, and Bhupender S Chhikara, and Guofeng Ye, and Sitaram Bhavaraju, and Ajay Dixit, and Anil Kumar, and Gustavo F Doncel, and Keykavous Parang
January 2022, Frontiers in chemistry,
Copied contents to your clipboard!